Application Nr Approved Date Route Status External Links
NDA050577 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Zanosar Is Indicated In The Treatment Of Metastatic Islet Cell Carcinoma Of The Pancreas. Responses Have Been Obtained With Both Functional And Nonfunctional Carcinomas. Because Of Its Inherent Renal Toxicity, Therapy With This Drug Should Be Limited To Patients With Symptomatic Or Progressive Metastatic Disease.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Streptozocin STREPTOZOCIN ZINC3977737

Comments